Shield Therapeutics (1JS) Q4 2021 Earnings Report
DE:1JS Q4 2021 EPS Results
- Actual EPS
- -EUR 0.05
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.05
DE:1JS Q4 2021 Revenue Results
- Actual Revenue
- EUR 2.37M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +38.35%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 09/08/2022
- Time
- Before Open
- Conference Call
- Thursday, September 8, 2022
DE:1JS Upcoming Earnings
Shield Therapeutics's next earnings date is estimated for April 29, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1JS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 29, 2027 | 2026 (Q4) | ―- | -0.01 | ― | ― |
| Aug 20, 2026 | 2026 (Q2) | ―0.00 | -0.01 | 100.00% (+0.01) | |
| Apr 09, 2026 | 2025 (Q4) | ―-0.01 | -0.02 | 60.00% (+0.01) | |
| Aug 21, 2025 | 2025 (Q2) | ―-0.01 | -0.02 | 50.00% (+0.01) | |
| Apr 24, 2025 | 2024 (Q4) | -0.02-0.01 | -0.02 | 31.82% (+0.01) | |
| Sep 04, 2024 | 2024 (Q2) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Apr 30, 2024 | 2023 (Q4) | ―-0.03 | -0.14 | 81.51% (+0.11) | |
| Sep 28, 2023 | 2023 (Q2) | ―-0.02 | -0.05 | 64.29% (+0.03) | |
| Apr 27, 2023 | 2022 (Q4) | ―-0.14 | -0.06 | -120.37% (-0.08) | |
| Sep 08, 2022 | 2021 (Q4) | ―-0.05 | -0.05 | -5.66% (-0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
